1. P228 Preliminary Evaluation of a new immunofluorescence mosaic assay for inflammatory bowel disease diagnosis: a pilot study in Udine. (25th January 2019) Authors: Fabris, M; Meroi, F; Cifu', A; Castagnaviz, E; Curcio, F; Terrosu, G; Scardino, G; Vadalà di Prampero, S F; Marino, M Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P612 Lack of seroconversion following COVID-19 vaccination, but not treatment, is an independent risk factor for breakthrough SARS-CoV-2 infection in patients with inflammatory bowel disease: data from ESCAPE - an IG-IBD Study. (30th January 2023) Authors: Macaluso, F S; Principi, M; Facciotti, F; Contaldo, A; Todeschini, A; Bezzio, C; Saibeni, S; Castiglione, F; Nardone, O M; Spagnuolo, R; Fantini, M C; Riguccio, G; Conforti, F S; Caprioli, F A; Viganò, C; Felice, C; Fiorino, G; Correale, C; Bodini, G; Milla, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗